SpyBiotech Overview

  • Founded
  • 2017
Founded
  • Status
  • Private
  • Employees
  • 11
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $32.4M
Latest Deal Amount
  • Investors
  • 5

SpyBiotech General Information

Description

Developer of vaccines intended to generate immunity against bacterial infections. The company develops bonding vaccines which are made from the proprietary protein superglue that is used to bond antigens to viruses and other particles to make vaccines, enabling medical institutions and research centers with a new and modified technology to develop vaccines that give better results in lesser time.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Other Pharmaceuticals and Biotechnology
Primary Office
  • 7600 Quorum
  • Oxford Business Park North
  • Oxford OX4 2JZ
  • England, United Kingdom
+44 01865 000000

SpyBiotech Timeline

2018201920202021
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

SpyBiotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 08-Feb-2021 $32.4M 000.00 000.00 Completed Clinical Trials - Phase 1
2. Early Stage VC 06-Jul-2018 00.000 00.00 000.00 Completed Startup
1. Seed Round 31-Mar-2017 $6.17M $6.17M 00.00 Completed Pre-Clinical Trials
To view SpyBiotech’s complete valuation and funding history, request access »

SpyBiotech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A2 000,000 00.000000 00.0 00.0 00 00.0 0.00
Series A1 0,000,000 00.000000 00.0 00.0 00 00.0 00.000
Series A1 0,000,000 00.000000 00.00 00.00 00 00.00 00.00
A Ordinary 4,000,000 $0.000137 $1.37 $1.37 1x $1.37 22.56%
Ordinary 1,000,000 $0.001366 $1.37 $1.37 1x $1.37 5.64%
To view SpyBiotech’s complete cap table history, request access »

SpyBiotech Executive Team (5)

Name Title Board Seat Contact Info
Sumi Biswas Co-Founder, Chief Executive Officer, Board Member and Chief Scientific Officer
Vien Phan Interim Director of Finance and Operations
Mark Howarth Co-Founder & Scientific Advisor
Simon Draper Co-Founder & Scientific Advisor
You’re viewing 4 of 5 executive team members. Get the full list »

SpyBiotech Board Members (8)

Name Representing Role Since
Andre Crawford-Brunt Self Board Member 000 0000
Daniel Menichella Self Board Member 000 0000
James Wong Self Board Member 000 0000
Lachlan MacKinnon Oxford Sciences Innovation Board Member 000 0000
Lutz Giebel Ph.D Self Non Executive Chairman 000 0000
You’re viewing 5 of 8 board members. Get the full list »

SpyBiotech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SpyBiotech Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Braavos Investment Advisers PE/Buyout Minority 000 0000 000000 0
Government of UK Government Minority 000 0000 000000 0
Oxford Investment Consultants Venture Capital Minority 000 0000 000000 0
GV Corporate Venture Capital Minority 000 0000 000000 0
Oxford Sciences Innovation Venture Capital Minority 000 0000 000000 0
To view SpyBiotech’s complete investors history, request access »